Price $10.62 |
Market Cap
892.2M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
20.1
|
P/B
-
|
P/S
0.83
|
Dividend %
3.70%
|
|
P/CF
34.3
|
P/FCF
14.5
|
Op. Cash Flow
96.1K
|
FCF
1.1
|
|
Op. Margin
17.30%
|
Net Margin
4.20%
|
ROE
-5.60%
|
ROI
36.80%
|
|
ROA
4.00%
|
EPS Growth
-86.10%
|
Current Ratio
2.2
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Generation Bio Co (GBIO) | $2.80 | - | - | 65.9M | Strong Buy |
| Rigel Pharmaceuticals Inc (RIGL) | $1.08 | - | - | 139.2M | Strong Buy |
| China SXT Pharmaceuticals Inc (SXTC) | $1.02 | - | - | 1.2M | Strong Buy |
| Jazz Pharmaceuticals PLC (JAZZ) | $109.94 | - | - | 8.13B | Strong Buy |
| ATI Physical Therapy Inc (ATIP) | $4.03 | - | - | 30.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
